Page last updated: 2024-12-05

trimecaine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Trimecaine: Acetanilide derivative used as a local anesthetic. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID12028
CHEMBL ID1618597
CHEBI ID135013
SCHEMBL ID24692
MeSH IDM0021982

Synonyms (52)

Synonym
CBMICRO_019206
3-12-00-02712 (beilstein handbook reference)
in1233r0jo ,
trimecaina
trimecainum
unii-in1233r0jo
trimecaine
acetamide, 2-(diethylamino)-n-(2,4,6-trimethylphenyl)-
2-(diethylamino)-2',4',6'-trimethylacetanilide
justecaina
brn 2697351
mesidicain
2-diethylamino-2',4',6'-trimethylacetanilide
2-(diethylamino)-n-(2,4,6-trimethylphenyl)acetamide
mesokain
mesidicaine
trimecaina [inn-spanish]
einecs 210-487-3
mesocain
acetanilide, 2-(diethylamino)-2',4',6'-trimethyl-
diethylglycinemesidide
trimecainum [inn-latin]
trimecaine [inn]
trimecain
NCGC00065440-02
CHEBI:135013
AKOS001589944
trimecaine (inn)
D08640
616-68-2
STK735536
n~2~,n~2~-diethyl-n-(2,4,6-trimethylphenyl)glycinamide
trimecaine [who-dd]
trimecaine [mi]
CHEMBL1618597
acetamide,2-(diethylamino)-n-(2,4,6-trimethylphenyl)-
SCHEMBL24692
DTXSID6048410
AM85847
n-(diethylaminoacetyl)-2,4,6-trimethylaniline
trimekain
.omega.-diethylaminoacetylaminomesitylene
2-(diethylamino)-n-mesitylacetamide #
mesdicain
GOZBHBFUQHMKQB-UHFFFAOYSA-N
mesocaine (salt/mix)
mesocain (salt/mix)
2-(diethylamino)-n-mesitylacetamide
n~2~,n~2~-diethyl-n~1~-mesitylglycinamide
Q3048749
BCP09485
2-(diethylamino)-n~1~-mesitylacetamide

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" Average individual values of distribution volumes in stationary condition and in the stage of elimination, clearance and half-life differed but insignificantly for trimecain and lidocain."( [Pharmacokinetic characteristics of trimecaine compared to lidocaine in myocardial infarct patients].
Metelitsa, VI; Piotrovskiĭ, VK; Riabokon', OS; Smirnova, EB, 1982
)
0.54

Compound-Compound Interactions

ExcerptReferenceRelevance
"The authors compare the efficacies of trimecaine (8 mg/kg), lidocaine (8 mg/kg), azacaine (2 and 3 mg/kg) alone and in combination with morphine (1."( [A comparative evaluation of the effects of local anesthetics combined with morphine and administered epidurally].
Cherniakova, IV; Kiselevich, VE; Korinenko, AN; Osipov, SA,
)
0.4

Dosage Studied

ExcerptRelevanceReference
"Rheological properties exert influence on the manufacturing processes, stability and usability of a dosage form as well as the biological availability of an active ingredient."( [Effect of polymer concentration on rheological properties of Carbopol 980 hydrogels containing trimecainium chloride].
Cirbusová, E; Erös, I; Kónya, M; Subová, M; Vitková, Z, 2005
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
amino acid amideAn amide of an amino acid formed formally by conversion of the carboxy group to a carboxamido group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (195)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990155 (79.49)18.7374
1990's25 (12.82)18.2507
2000's8 (4.10)29.6817
2010's4 (2.05)24.3611
2020's3 (1.54)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.61

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.61 (24.57)
Research Supply Index5.76 (2.92)
Research Growth Index4.20 (4.65)
Search Engine Demand Index36.32 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.61)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials18 (6.04%)5.53%
Reviews1 (0.34%)6.00%
Case Studies17 (5.70%)4.05%
Observational0 (0.00%)0.25%
Other262 (87.92%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]